Singapore, Singapore

Zuyong Wang

This inventor holds 1 USPTO granted patent. Top assignee: National University of Singapore. Active years: 2020.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Zuyong Wang in Tissue Engineering

Introduction

Zuyong Wang is a notable inventor based in Singapore, recognized for his contributions to the field of tissue engineering. He has developed innovative solutions that aim to improve medical treatments and enhance the quality of life for patients. His work is particularly focused on creating advanced tissue scaffold devices.

Latest Patents

Zuyong Wang holds a patent for a "Tissue scaffold device and method for fabricating thereof." This invention includes a porous core made up of a plurality of fibers, along with an outer portion that substantially surrounds the core. The outer portion features a plurality of pores that are elongated along the longitudinal axis of the tissue scaffold device. This design is intended to facilitate better integration with biological tissues.

Career Highlights

Zuyong Wang is affiliated with the National University of Singapore, where he conducts research and develops innovative technologies in the field of biomedical engineering. His work has garnered attention for its potential applications in regenerative medicine and tissue repair.

Collaborations

Zuyong Wang has collaborated with several colleagues, including Eng San Thian and Ee Jen Wilson Wang. These partnerships have contributed to the advancement of research in tissue engineering and have led to significant developments in the field.

Conclusion

Zuyong Wang's contributions to tissue engineering through his innovative patent demonstrate his commitment to advancing medical technology. His work continues to inspire future research and development in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…